Michael W. Nall
President and Chief Executive Officer
Mr. Nall has over 30 years of healthcare leadership experience and has been our President and CEO since 2013. During this time, the company has transitioned from R and D to Commercialization. Mr. Nall has previously served in Commercial and Operational leadership roles in multiple companies including his most recent role as General Manager, North America Sales and Marketing for GE Healthcare’s Clarient division, leading all aspects of commercialization including Sales, Marketing and Reimbursement for Laboratory Services. Prior to Clarient, Mr. Nall served at Impath, Maquet Surgical, Midwest Medical, CVS Specialty Distribution and American Cyanamid.
Mr. Nall also serves on a non-profit board for the Clearity Foundation which is dedicated to providing support for women diagnosed with Ovarian Cancer.
Chief Operating Officer and Chief Financial Officer
Tim Kennedy brings more than 30 years of financial and operational leadership experience, including over 25 years in the clinical diagnostics industry. Most recently, Tim served as Chief Financial Officer of Millennium Health, a privately held leading urine drug testing and pharmacogenetics laboratory company. Prior to Millennium, he held various leadership positions at leading companies, such as PLUS Diagnostics, Diagnostic Imaging Management and National Health Laboratories (presently known as LabCorp). Tim holds a bachelor’s degree in Business – Accounting/Information Technology from Keane University.
Michael C. Dugan, M.D.
Senior Vice President, Chief Medical Officer and Medical Director
Dr. Dugan leads our clinical strategic development as CMO and oversees our CAP accredited CLIA clinical laboratory as Medical Director. He is an experienced physician and biotech executive who has directed several major commercial reference laboratories and helped launch numerous novel molecular diagnostic assays and platforms used in oncology, infectious disease and public health applications such as cancer screening, monitoring, diagnosis and therapy selection. Dr. Dugan has held leadership positions with Clinical Genomics, Exact Sciences, Genzyme Genetics (acquired by LabCorp), Quest Diagnostics (including acquired companies AmeriPath and Specialty Laboratories), and UCLA.
A graduate of the University of Notre Dame (B.S. Biology) and University of Arizona College of Medicine (M.D.), he completed his post-graduate medical education in anatomic pathology at Yale-New Haven Hospital and continued training in pathology and laboratory medicine at Children’s Hospital Los Angeles and UCLA. He is board-certified in Anatomic and Clinical Pathology.
Randy Goodman, Ph.D.
Senior Director, Head of Managed Care
Dr. Randy Goodman has over 25 years of experience in healthcare and medical policy, health economics and outcomes research, value-based dossier development, market access strategy development, patient outcomes, pricing and reimbursement strategy development in both private industry global markets as well as healthcare consulting services, including senior leadership and project management roles.
Randy received both his Master’s degree and his PhD in Healthcare Administration and Policy (Health Economics) from Harvard University, Chan School of Public Health. Randy is a fellow, American College of Healthcare Executives and has published several papers on HEOR trends both here in the U.S. and in Europe. These publications include health economic models that were included in the Affordable Care Act and the 21st Century Cures Act. Randy recently became board certified as a Medical Affairs Specialist.
Darrell Taylor, Esq.
Senior Vice President, General Counsel and Chief Compliance Officer
Darrell Taylor brings more than 30 years of healthcare and leadership experience, including over 20 years as a healthcare attorney. He is an experienced attorney who has provided legal regulatory and compliance counsel to global biopharmaceutical companies as well as numerous biotech start-ups. Most recently, Darrell served as Chief Compliance Officer for Precision Diagnostics and its CLIA-certified and CAP-accredited clinical laboratory.
Previous to his in-house positions, Darrell honed his skills as an attorney with the global law firm, DLA Piper, serving healthcare companies, biopharma, private equity, venture capital, institutional investors, and providers by assisting them with navigating opportunities in this highly complex, heavily regulated, and ever-changing industry. Darrell earned his J.D. from the University of Notre Dame Law School and his B.S.M.T., with high honors, at The University of Texas Medical Branch.
Senior Vice President, Corporate Development
Mike Terry is a seasoned veteran in the molecular diagnostics and liquid biopsy industries, Mike has vast leadership experience managing large and small commercial teams. Prior to Biocept, he served as Executive Vice President of Sequenom, Inc., and more recently Trovagene, Inc. He also has held leadership positions at GE Healthcare’s Marquette Medical division, Lumenis Ltd, Aspect Medical Systems Inc. and Ligand Diagnostics.
Senior Vice President, Commercial Operations
Dave Karlander leads our sales, marketing and managed care teams and brings over 25 years of experience successfully building and managing major brands in diagnostics, devices, and pharmaceuticals. His previous experience includes executive sales and marketing positions at Exact Sciences and Novartis’ Genoptix Medical Lab, where he led successful campaigns to expand product pipelines, reimbursement rates and sales volumes, among other responsibilities. Dave earned his MBA from Northwestern University’s Kellogg Graduate School of Management, and a Bachelor of Science from Miami University.
Senior Director, Quality
Tom Nauman is a 30-year professional in the bio-tech field including 25 years in Quality Assurance and eight years in positions as Director of Quality. He has worked for such companies as Genoptics / Novartis, Accriva / Instrumentation Laboratory, Abbott Laboratories, Becton Dickinson, and Covidien / Medtronic. Tom received a Bachelor of Science degree in Industrial Engineering from Iowa State University.
Vice President, Sales
Antonio Paternostro brings over 15 years of Sales leadership experience in the clinical diagnostics, anatomic pathology, and biotechnology industries. Antonio served multiple commercial leadership positions at PLUS DX, Miraca Life Sciences and most recently GenomeDx Biosciences (now Decipher Biosciences). Antonio holds a Bachelor of Science degree in Biology and Secondary Education from Central Connecticut State University.
Senior Director, Product Development
Tim Schofield has over twenty years of sales and marketing experience working in pharmaceuticals, clinical diagnostics and life sciences. He started his career with Johnson & Johnson and has held commercial leadership roles at Prometheus Laboratories, NanoString and Nucleus Biologics. Tim received his Bachelor of Arts in Business Administration from Western Washington University and an MBA from Willamette University.